Perflutren Lipid Microspheres: Clinical Trials

12 trials of Perflutren Lipid Microspheres, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 active not recruiting, 2 recruiting, 1 unknown. 6 Not applicable, 3 Phase 1, 2 Phase 3, 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 3, Recruiting 1, Unknown 1, Withdrawn 1
Phase 13Completed 2, Recruiting 1
Phase 32Active not recruiting 2
Early Phase 11Completed 1
Phase 21Active not recruiting 1

Follow Perflutren Lipid Microspheres: new trials by email Literature Review of Perflutren Lipid Microspheres trials Research Report on Perflutren Lipid Microspheres

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension
Electronic Health Record Review, Liver Biopsy, Medical Device Usage and Evaluation - Portal Hypertension
Not applicableRecruitingMayo Clinic602025-03-132026-08-14
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)
Perflutren Lipid Microspheres, Ultrasound - Prostate Carcinoma
Phase 3Active not recruitingThomas Jefferson University702022-06-152025-09-04
SHAPE Neoadjuvant Chemotherapy Response
Contrast-Enhanced Ultrasound, Perflutren Lipid Microspheres, Ultrasound - Anatomic Stage III Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma
Phase 2 / Phase 3Active not recruitingKibo Nam1222021-04-192026-09-23
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
Contrast-Enhanced Ultrasound, Perflutren Lipid Microspheres, Sulfur Hexafluoride Lipid Microspheres - Breast Carcinoma
Phase 1RecruitingUniversity of Southern California1002020-11-052026-02-02
Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization
Perflutren Lipid Microspheres, Sulfur Hexafluoride Lipid Microspheres, Dynamic Contrast-Enhanced Ultrasound Imaging - Hepatocellular Carcinoma
Not applicableWithdrawnUniversity of Southern California2017-11-072019-05-16
Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery
Perflutren Lipid Microspheres, Contrast-Enhanced Subharmonic Ultrasound Imaging - Adnexal Mass
Early Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University122017-08-012025-05-15
Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation
perflutren lipid microspheres, 3D ultrasound - Liver Cancer, Liver Tumor
Not applicableCompletedStanford University112014-11-182023-07-11
Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy
Definity infusion - Breast Cancer
Not applicableCompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University172014-03-012025-05-06
Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads
Perflutren Lipid Microspheres, Dynamic Contrast-Enhanced Ultrasound Imaging, Contrast-enhanced Magnetic Resonance Imaging - Hepatocellular Carcinoma
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University152012-12-122025-05-02
Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
perflutren lipid microspheres - Liver Neoplasms
Not applicableCompletedUniversity of California, Davis82007-04-012017-07-11
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
Definity, medical chart review - Ovarian Cancer
Phase 1CompletedIcahn School of Medicine at Mount Sinai672007-01-012017-04-18
Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound
perflutren lipid microspheres - Kidney
Not applicableUnknownUniversity of Virginia202006-06-012008-08-07

Conditions studied

Carcinoma, Hepatocellular (3)  ·  Breast Neoplasms (2)  ·  Liver Neoplasms (2)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Hypertension, Portal (1)  ·  Ovarian Neoplasms (1)  ·  Prostatic Neoplasms (1)

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (3)  ·  University of Southern California (2)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Kibo Nam (1)  ·  Mayo Clinic (1)  ·  Stanford University (1)  ·  Thomas Jefferson University (1)  ·  University of California, Davis (1)  ·  University of Virginia (1)

Countries

United States (11)  ·  Netherlands (1)

Top investigators

Flemming Forsberg, PhD (3)  ·  Arthur C. Fleischer, MD (1)  ·  Bino A Varghese, PhD (1)  ·  Daniel T. Chang (1)  ·  David Fishman, MD (1)  ·  Harshawn Malhi, MD (1)  ·  Jaydev K. Dave, PhD (1)  ·  John P. McGahan, M.D. (1)  ·  Kambiz Kalantarinia, MD (1)  ·  Kibo Nam, MD (1)

Results publications

PMID 22619674

NIH funding

P30CA014089 (2), P30CA068485 (1), R01CA252311 (1), R21CA190930 (1), R37CA234428 (1)